Nuclear medicine methods in the diagnosis and treatmentof high-risk neuroblastoma - case report
DOI:
https://doi.org/10.13112/PC.2024.16Keywords:
neuroblastoma, radionuclide imaging, 3-iodobenzylguanidineAbstract
Neuroblastoma is childhood’s most common extracranial solid tumor, with a broad spectrum of biological conduct. The high-risk disease encompasses a significant portion of childhood cancer mortality. Nuclear medicine methods, including disease risk categorization, are essential in the diagnostic process. However, nuclear medicine has its place as a segment of the multidisciplinary treatment of high-risk diseases, too. In this article, a patient diagnosed with high-risk neuroblastoma due to age and metastases is presented, with an accent on the role of nuclear medicine and a multidisciplinary approach in diagnostic and therapeutic procedures.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Vedrana Gladić Nenadić, Nada Rajacic
This work is licensed under a Creative Commons Attribution 4.0 International License.
By publishing in Paediatria Croatica, authors retain the copyright to their work and grant others the right to use, reproduce, and share their research articles in accordance with the Creative Commons Attribution License (CC BY 4.0), which allows others to distribute and build upon the work as long as they credit the author for the original creation.
